HomeVRPX • NASDAQ
add
Virpax Pharmaceuticals Inc
Previous close
$2.87
Day range
$3.07 - $3.28
Year range
$2.40 - $11.77
Market cap
3.63M USD
Avg Volume
15.84K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 918.10K | -16.69% |
Net income | -4.56M | -52.71% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 9.14M | -51.87% |
Total assets | 9.63M | -51.06% |
Total liabilities | 7.69M | 148.63% |
Total equity | 1.93M | — |
Shares outstanding | 1.17M | — |
Price to book | 1.74 | — |
Return on assets | -20.25% | — |
Return on capital | -54.39% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -4.56M | -52.71% |
Cash from operations | -3.01M | -92.14% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -3.01M | -92.14% |
Free cash flow | 976.42K | 33.58% |
About
Founded
2016
Headquarters
Website
Employees
7